Detalhe da pesquisa
1.
Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
J Clin Rheumatol
; 30(1): e9-e17, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936271
2.
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status.
Rheumatology (Oxford)
; 62(4): 1621-1626, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124987
3.
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry).
J Clin Rheumatol
; 29(2): 68-77, 2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454054
4.
Disease activity and subcutaneous nodules are associated to severe periodontitis in patients with rheumatoid arthritis.
Rheumatol Int
; 42(8): 1331-1339, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34420067
5.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Ann Rheum Dis
; 80(9): 1137-1146, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049860
6.
Depression Is a Major Determinant of Functional Capacity in Rheumatoid Arthritis.
J Clin Rheumatol
; 27(6S): S180-S185, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732521
7.
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Lupus
; 29(14): 1866-1872, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028177
8.
[Tubulointerstitial nephritis syndrome and uveitis]. / Síndrome de nefritis túbulo-intersticial agudo asociado a uveítis.
Medicina (B Aires)
; 76(6): 376-378, 2016.
Artigo
em Espanhol
| MEDLINE | ID: mdl-27959848
9.
Humoral and T Cell Response to SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis.
Arthritis Care Res (Hoboken)
; 76(1): 120-130, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605835
10.
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry.
Arthritis Care Res (Hoboken)
; 76(2): 274-287, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37643903
11.
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Clin Rheumatol
; 42(2): 563-578, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201124
12.
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Clin Rheumatol
; 41(10): 3199-3209, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760939
13.
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
J Rheumatol
; 49(12): 1385-1389, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182107
14.
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.
ACR Open Rheumatol
; 4(10): 872-882, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869686
15.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
JAMA Netw Open
; 4(10): e2129639, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661663
16.
A useful tool to assess quality of LIFE in rheumatoid arthritis patients that does not require a license: QOL-RA II.
Clin Rheumatol
; 39(11): 3309-3315, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430630
17.
Reply.
Arthritis Care Res (Hoboken)
; 76(4): 583-584, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823240
18.
Seguridad de las drogas biológicas y sintéticas dirigidas utilizadas en pacientes con enfermedades reumáticas inmunomediadas. Datos del registro BIOBADASAR 3.0 / Safety of biological and targeted synthetic drugs in patients with immune-mediated rheumatic diseases. Data from the BIOBADASAR 3.0 registry
Rev. argent. reumatolg. (En línea)
; 34(1): 3-15, ene. 2023. tab
Artigo
em Espanhol
| BINACIS, LILACS | ID: biblio-1449435
19.
Frecuencia de infección por SARS-CoV-2 en asistentes a un congreso médico en la Ciudad Autónoma de Buenos Aires. Datos del Congreso Argentino de Reumatología 2021 / Frequency of SARS-CoV-2 infection in attendees at a medical congress in the Autonomous City of Buenos Aires. Data from the Argentine Congress of Rheumatology 2021
Rev. argent. reumatolg. (En línea)
; 33(2): 67-75, abr. - jun. 2022. ilus
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1393386
20.
Frecuencia de comorbilidades en pacientes con artritis psoriásica y evaluación de la adherencia de los médicos a las recomendaciones de tratamiento de las Guías GRAPPA 2015 / Frequency of comorbidities in patients with psoriatic arthritis and evaluation of the adherence of physicians to the treatment recommendations of the GRAPPA 2015 Guidelines
Rev. argent. reumatolg. (En línea)
; 33(4): 205-214, oct. 2022. tab, graf
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1449425